BOSTON (AP) — BOSTON (AP) — Spectrum Pharmaceuticals Inc. (SPPI) on Wednesday reported a loss of $9 million in its fourth quarter.

The Boston-based company said it had a loss of 5 cents per share. Losses, adjusted to account for discontinued operations, came to 6 cents per share.

The biotechnology company posted revenue of $10.1 million in the period.

For the year, the company reported a loss of $75.4 million, or 41 cents per share. Revenue was reported as $10.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SPPI at https://www.zacks.com/ap/SPPI

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News